Matinas BioPharma Holdings (MTNB) Price to Sales (2015 - 2023)
Matinas BioPharma Holdings' (MTNB) Price to Sales was 2140.93 for Q4 2023, up 25.7% from 1703.41 a year earlier and up 227.3% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Price to Sales (2015 - 2023) Analysis & Trends
Dating back to Q2 2015, Matinas BioPharma Holdings' Price to Sales record includes 29 quarters.
- By year, Price to Sales came in at 1703.77 in FY2022 (-99.5%), 330957.79 in FY2021 (+285.1%), 85943.63 in FY2020 (-58.3%) and 206189.79 in FY2019 (+632.6%).
- The Q4 2023 figure ranks as the highest quarterly Price to Sales since Q3 2022.
- Year over year, Price to Sales gained in 1 of the last six quarters, with an average decline of 69.6%.
- The high point for year-over-year Price to Sales in five years was Q4 2019 (growth of 632.6%); the low point was Q4 2022 (a decline of 99.5%).
- Per Business Quant data, the three quarters before Q4 2023 came in at 654.11 (Q3 2023), 1213.77 (Q2 2023) and 1191.53 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Matinas BioPharma Holdings | 508,224.03 | -12.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 142.73 |
| Sep 30, 2023 | 43.61 |
| Jun 30, 2023 | 80.92 |
| Mar 31, 2023 | 79.44 |
| Dec 31, 2022 | 113.56 |
| Sep 30, 2022 | 216.29 |
| Jun 30, 2022 | 537.40 |
| Dec 31, 2021 | 22,063.85 |
| Sep 30, 2021 | 9,778.18 |
| Jun 30, 2021 | 2,892.82 |
| Mar 31, 2021 | 3,730.42 |
| Dec 31, 2020 | 5,729.58 |
| Sep 30, 2020 | 2,736.60 |
| Dec 31, 2019 | 0.00 |
| Sep 30, 2019 | 0.00 |
| Jun 30, 2019 | 0.00 |
| Mar 31, 2019 | 0.00 |
| Dec 31, 2018 | 1,876.30 |
| Sep 30, 2018 | 1,819.58 |
| Jun 30, 2018 | 650.54 |
API Access
Matinas BioPharma Holdings Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();